Introduction
Apart from fully differentiated cells, apparently all postnatal mammalian tissues contain rare and quiescent stem cells that have the capacity for self-renewal and initiating differentiated descendants [1, 2] . Mesenchymal stem cells are an uncommon population present in the bone marrow and tissues, such as the adipose tissue, synovium, dermis, periosteum, and deciduous teeth. During isolation and expansion in vitro mesenchymal stem cells constitute a minor fraction (b1%) of the total mesenchymal stromal cell (MSC) population. The increasing body of evidence points to the intrinsic, and donor-to-donor heterogeneity of MSC populations [3] [4] [5] . One of the pioneering demonstrations of populational diversity was provided by the microSAGE assay of MSC colonies derived from a single human bone marrow cell. The expression analysis revealed transcripts for more than 2000 genes encoding proteins known to regulate angiogenesis, cell motility, hematopoiesis, immunity, and neural activities [6, 7] . It seems to be highly unlikely if an individual cell would be capable of fulfilling all these autonomous physiological functions. Consistently, immunostaining data suggested a non-uniform pattern of protein expression [7] . It was therefore postulated that a variety of functional attributes characteristic of the entire MSC population was determined by separate subpopulations. The concept of intrinsic heterogeneity of a MSC population is well consistent with the finding that a MSC colony can release a broad array of signaling molecules, including FGF-2, BDNF, IGF1, ANG1 and certain cytokines and chemokines [8] . Although mammalian MSCs are poorly characterized in terms of intracellular signaling and ionic mechanisms of electrogenesis, available reports also evidence for molecular and functional heterogeneity of MSC populations [9, 10] .
Several key factors determine cell proliferation and differentiation, including intrinsic genetic programs, intracellular signaling, and local environmental cues. Reportedly, spontaneous Ca 2+ oscillations and induced Ca 2+ transients can mediate development, from fertilization through proliferation and differentiation to organogenesis, and expansion of progenitor pools [11] [12] [13] . Thus, membrane receptors and regulatory 
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Biochimica et Biophysica Acta j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / b b a m c r pathways associated with intracellular Ca 2+ signaling can be critically important for tissue development and regeneration. Although a role of ion channels is much less obvious, they may also be involved in coordinating extracellular and intracellular signals associated with cell proliferation and differentiation [10, [14] [15] [16] . Specifically, ion channels can regulate exocytosis of autocrine and paracrine factors by determining membrane potential and Ca 2+ influx [16] . Transmembrane ion fluxes drive cell volume oscillations in cycling and migrating cells [17, 18] . Yet, ion channels are capable of modulating cell proliferation and differentiation via flux-independent mechanisms, including association of channel proteins with membrane receptors and related proteins [19] [20] [21] [22] .
In light of molecular and functional heterogeneity of a MSC population posed by the abovementioned facts, the important possibility is that molecular and functional phenotypes of these cells may be in strong correlation. If so, an individual MSC subpopulation with a specific molecular profile could be revealed physiologically and described in terms of responsivity to agonists, Ca 2+ signaling pathways, and/or activity of ion channels. We therefore attempted to characterize responsiveness of adipose-derived human MSCs to a variety of agonists, such as ACh, ATP, noradrenaline, serotonin, and some others, which are known to mobilize cytosolic Ca 2+ in cells of diverse types. All first messengers probed by us were found to stimulate Ca 2+ signaling in MSCs.
Since apart from ATP, a given cell usually responded to one of them, it appears that different MSC subpopulations can indeed be classified based on functional criteria. Here we focused largely on the analysis of MSCs responsive to noradrenaline, given some interesting aspects of Ca 2+ signaling in adrenergic cells.
Materials and methods

Cell isolation and culturing
Human MSCs were isolated from abdominal subcutaneous adipose tissue harvested during surgical operations from patients at age within 32-60 years. All donors gave informed consent for harvesting their adipose tissue. Donors with infectious or systemic diseases and malignancies were not included in the study. Adipose tissue was extensively washed with 2 volumes of Hank's Balanced Salt Solution (HBSS) containing 1% antibiotic/antimycotic solution (HyClone) and then digested at 37°C for 1 h in the presence of collagenase (66.7 U/ml, SigmaAldrich) and dispase (10 U/ml, BD Biosciences). Enzymatic activity was neutralized by adding an equal volume of culture medium (AdvanceStem basal medium for human undifferentiated mesenchymal stem cells (HyClone) containing 10% of Advance stem cell growth supplement (CGS) (HyClone), 1% antibiotic/antimycotic solution) and centrifuged at 200 g for 10 min. This led to sedimentation of diverse cells, including MSCs, macrophages, lymphocytes, and erythrocytes, while mature adipocytes remained floating. After removal of supernatant, a lysis solution (154 mM NH 4 Cl, 10 mM KHCO 3 , and 0.1 mM EDTA) was added to a cell pellet to lyse erythrocytes, and cell suspension was centrifuged at 200 g for 10 min. Sedimented cells were resuspended in the MSC culture medium and filtered through a 100 μm nylon cell strainer (BD Biosciences). As indicated by flow cytometry data (Supplementary Materials, Fig. 1S ), after isolation and overnight pre-plating, the obtained cell population contained largely not only MSC cells but also macrophages and lymphocytes. The two last cell groups were dramatically depleted by culturing during 1 week in the MSC culture medium and humidified atmosphere (5% CO 2 ) at 37°C. The obtained MSC population was maintained at a sub-confluent level (b80% confluency) and passaged using HyQTase (HyClone). For experiments, cells of the second to fourth passages were used.
Preparation of cells for Ca 2+ imaging
Before assaying with Ca 2+ imaging, cells were maintained in a 12-socket plate for 12 h in the medium described above but without antibiotics. For isolation, cells cultured in a 1 ml socket were rinsed twice with the Versen solution (Sigma-Aldrich) that was then substituted for 0.2 ml HyQTase solution (HyClone) for 3-5 min. The enzymatic treatment was terminated by the addition of a 0.8 ml culture medium to a socket. Next, cells were resuspended, put into a tube, and centrifuged at 0. Most of experiments were carried out using an inverted fluorescent microscope Axiovert 135 equipped with an objective Plan NeoFluar 20x/0.75 (Zeiss) and a digital ECCD camera LucaR (Andor Technology). Apart from a transparent light illuminator, the microscope was equipped with a hand-made system for epi-illumination via an objective. The epi-illumination was performed using a bifurcational glass fiber. One channel, which was used for Fluo-4 excitation, transmitted 480 ± 5 nm irradiation emitted by LED controlled by a computer. Fluo-4 emission was collected at 535 ± 20 nm. Serial fluorescent images were captured every second and analyzed using Imaging Workbench 6 software (INDEC). Deviations of cytosolic Ca 2+ from the resting level were quantified by a relative change in the intensity of Fluo-4 fluorescence (ΔF/F 0 ) recorded from an individual cell. Another channel was connected to a pulsed solid laser DTL-374QT (30 mW) (Laser-Export, Moscow). This unit operated in a two-harmonic mode and generated not only 355 nM UV light used for Ca 2+ uncaging but also visible light at 532 nm. The last could penetrate into an emission channel through non-ideal optical filters and elicited optical artifacts during uncaging. For Ca 2+ uncaging, cells were loaded with both 4 μM Fluo-4 and NP-EGTA (both from Invitrogen). Other compounds were from Sigma-Aldrich or Tocris.
Immunofluorescent analysis
For immunofluorescence analysis cultured cells were washed with PBS and fixed in 4% formaldehyde for 4 min at room temperature. Cells were then washed with PBS. Nonspecific binding was blocked by incubation in 1% BSA with 10% serum of secondary antibody donor for 30 min. Immunostaining was performed using mouse antibody against human α1-adrenoreceptor (Abbiotec) and rabbit polyclonal antibody against the human α2-adrenoreceptor (Thermo Sci). Cells stained with primary antibodies were then incubated in the presence of secondary antibodies, Alexa goat anti-rabbit 488 (Molecular Probes, Carlsbad, CA) or Alexa goat anti-mouse 488 (Molecular Probes). Cells were counterstained with nuclear 4,6-diamidino-2-phenylindole (Molecular Probes). As a negative control, cells were treated with mouse or rabbit nonspecific IgGs at relevant concentrations. Immunofluorescence was captured using a Leica DM6000 microscope equipped with a Leica DFC360 FX camera and Las AF software (Leica).
RT-PCR
Total RNA was extracted from a sample containing 10 5 -10
6 MSCs by using the RNeasy mini kit (Qiagen). Isolated RNA was treated with DNase I (Ambion) and reverse-transcribed with Superscript III reverse transcriptase (Invitrogen), following the manufacturer's instruction. Obtained cDNA served as a template for PCR with gene-specific primers that were designed for all human adrenoreceptor genes and for some marker genes, including CD73, CD90, and CD105 (Supplementary Materials, Table 1S ). The expected sizes of PCR products were as follows: 259 bp for ADRA1A (α1A), 379 bp for ADRA1B (α1B), 285 bp for ADRA1D (α1D), 347 bp for ADRA2A (α2A), 353 bp for ADRA2B (α2B), 291 bp for ADRA2C (α2C), 397 bp for ADRB1 (β1), 218 bp for ADRB2 (β2), 361 bp for ADRB3 (β3), 266 bp for CD73, 344 bp for CD90, and 300 bp for CD105.
Results
We loaded human MSCs with Fluo-4 and assayed their responsivity to different messengers using Ca 2+ imaging. Functional heterogeneity was characteristic of MSCs. Although a variety of GPCR agonists was found to stimulate Ca 2+ signaling in MSCs, in a whole MSC population, only a relatively small group of cells was specifically responsive to the particular agonist, including ATP, noradrenaline or adrenaline, serotonin, GABA, acetylcholine or its analog carbachol ( Fig. 1) , and glutamate (not shown). Basically, a given cell was either irresponsive to all stimuli or responded to one, rarely two, particular compound ( 958 MSCs were sequentially stimulated by multiple agonists, and 302 cells (31%) responded to some of them. In a subpopulation of irresponsive MSCs, certain cells (2-5% depending on a sample) generated spontaneous Ca 2+ oscillations under our recording conditions (Fig. 1F ).
ATP-sensitive cells (n = 112) composed the most abundant subgroup (37%), while adenosine and glutamate were the least effective agonists, being capable of mobilizing intracellular Ca 2+ solely in 8 (2.6%) and 11 (3.6%) cells, respectively (Fig. 1G ).
Here we focused on adrenergic signaling in MSCs. Because the effects of adrenaline and noradrenaline were identical, solely experiments with more frequently used noradrenaline are described below. Overall, more than 500 MSCs were distinguished by their ability to generate robust and reproducible Ca 2+ transients on noradrenaline and its analogs. We first attempted to evaluate a part of Ca 2+ release and Ca 2+ entry, the primary contributors to intracellular Ca 2+ signaling, in noradrenaline responses. It was particularly found that the inhibitor of phospholipase C (PLC) U73122 (1-5 μM) rendered MSCs insensitive to noradrenaline, while the much less effective analog U73343 never exerted such effects at concentrations of up to 10 μM ( Fig. 2A) 
Dose-response curve
The interesting feature of adrenergic MSCs was that Ca 2+ responses varied with noradrenaline concentration in a surprising "all-or-nothing" fashion (Fig. 3) . In other words, noradrenaline never caused detectable effects, when applied below 100 nM, while at exceeding concentrations, it elicited marked Ca 2+ transients of maximal or close magnitude in most cases (Fig. 3A, B) . In designated experiments, we evaluated the dose-response curves of individual cells by stimulating them with noradrenaline at gradually varied concentrations. Among the 37 cells examined, 29 cells exhibited robust responses in the whole range of agonist concentrations (30 nM-10 μM) (e.g. Fig. 3B ) with the threshold of 100-200 nM (Fig. 3C, D) . We categorized adrenergic MSCs into two groups based on their dose-response curves. One included possibly most robust cells (n = 21), which responded to noradrenaline with similar Ca 2+ transients irrespective of agonist concentration (Fig. 3B,   C ). Another group (n = 8) united cells with somewhat irregular dose dependencies (Fig. 3D ). Among them, 5 cells exhibited large (65-75%) but not maximal responses at the threshold stimulation and generated increasing Ca 2+ transients on rising noradrenaline (Fig. 3D ). Three cells generated the maximal responses at the threshold but showed irregularly varied lower responses as agonist concentration increased. Whatever the case, characteristic of all adrenergic MSCs was that none of them exhibited small Ca 2+ responses to noradrenaline at the threshold concentrations (Fig. 3) . One more notable feature of noradrenaline responses was that they were markedly postponed relative to a moment of agonist application. The characteristic time of response delay (τ d , Fig. 3E ) gradually decreased with noradrenaline concentration (Fig. 3F) . Particularly, Ca 2+ transients were retarded by 38-55 s at the threshold stimulation (Fig. 3E, left response) , whereas the delay was reduced to 17-26 s at the concentration of 1 μM and higher (Fig. 3E , right response), albeit response magnitude was not so variable (Fig. 3E) . As discussed later, two primary mechanisms may be responsible for specific dependencies of the magnitude and delay of cellular responses on agonist concentration.
Ca
2+
-induced Ca 2+ release as a likely contributor A variety of diverse cells exemplify a monotonic and gradual dependence of cellular responses on agonist concentration, including those that employ the phosphoinositide cascade for coupling GPCRs to Ca 2+ mobilization [26] [27] [28] . All-or-nothing responses of MSCs to noradrenaline (Fig. 3) could hardly be accounted for by a transduction process that involves solely PLC stimulation and IP 3 production followed by Ca 2+ release via IP 3 receptors (Fig. 2) . We therefore assumed that
MSCs generated responses to noradrenaline in two consecutive steps. transients that exceeded a response to a 2-s pulse by an order of magnitude (Fig. 4A) . With the exception of CICR, none of the known Ca 2+ -dependent mechanisms could amplify and shape an initial Ca 2+ signal produced by the NP-EGTA photolysis in such a way (Fig. 4A , response 1 vs. response 2). In addition, the representative cell (Fig. 4A ) was insensitive to 50 nM noradrenaline but similarly responded to the agonist at the 0.5 μM and 1 μM concentrations. Notably, the noradrenaline responses and light responses were quite similar in their shape and magnitude (Fig. 4B , thin line and circles). Similar results were obtained with other 8 MSCs that tolerated prolonged serial stimulation with both UV and noradrenaline. The overall data are partly summarized in Fig. 4C . Here each symbol represents agonist response versus light response, both being recorded from the same cell sequentially stimulated by a 6-s UV pulse and 0.5 μM noradrenaline (Fig. 4A) . The linear regression with the slope of 0.96 (solid line) satisfactorily fits the depicted data. Thus, the marked feature of adrenergic MSCs was all-or-nothing responsivity to both noradrenaline and Ca 2+ uncaging. Besides, Ca 2+ transients elicited by the agonist and light were very close kinetically and by magnitude. Theoretically, Ca 2+ uncaging could stimulate Ca 2+ -dependent PLC [33, 34] . This would result in IP 3 production and Ca 2+ release, thereby simulating noradrenaline responses. To check such a possibility, several adrenergic MSCs (n = 7) loaded with NP-EGTA were subjected to Ca 2+ uncaging in the presence of U73122. Although this PLC inhibitor expectedly rendered cells irresponsive to noradrenaline, they normally responded to UV flashes (Fig. 4D ). These findings left little doubt that Ca 2+ uncaging elicited noradrenaline-like responses exclusively by triggering CICR in the MSC cytoplasm. This inference was completely supported by independent evidence coming from the analysis of Ca 2+ waves in MSCs (Supplementary Fig. 2S ). At the moment solely ryanodine and inositol 1,4,5-trisphosphate (IP 3 ) receptors, both being Ca 2+ -gated Ca 2+ -release channels operating in the endo/sarcoplasmic reticulum are known to mediate CICR in a variety of different cells [31, 33, 35] . A number of noradrenaline responsive MSCs (n = 17) were pre-incubated with 50 μM ryanodine for about 200 s. Although ryanodine receptors should have been inhibited completely under these conditions, sensitivity of such cells to noradrenaline altered insignificantly (Fig. 5A) . In contrast, MSCs were rendered irresponsive by 2-APB (50 μM), an IP 3 receptor antagonist (Fig. 5A ) (n = 15). Moreover, in experiments, wherein cells loaded with NP-EGTA were stimulated by both noradrenaline and UV pulses, ryanodine did not suppress responses to either of the stimuli, whereas 2-APB reversibly inhibited CICR initiated by Ca 2+ uncaging (n = 7) (Fig. 5B) .
It thus appears that just IP 3 receptors are mainly responsible for CICR in adrenergic MSCs. This inference is consistent with the work by Kawano et al. [36] , which found no evidence for the expression of ryanodine receptors but detected transcripts for all three IP 3 receptor isoforms in MSCs derived from the human bone marrow.
Adrenoreceptor subtypes
In light of the abovementioned functional tests, we were interested in the molecular identity of adrenoreceptors operative in MSCs. The RT-PCR analysis was performed using RNA isolated from multiple MSC samples that were derived from the adipose tissue of 12 different donors. Specific primers were designed based on available sequences of all 9 genes encoding human adrenoreceptors [37] (Supplementary  Table 1S ). It is noteworthy that all RNA samples contained transcripts for α1B-, α2A-, and β2-adrenoreceptors as well as for CD73, CD90, and CD105 (Fig. 6 ) that are conventionally considered as MSC markers [4, 38] . The expression of α1-and α2-adrenoreceptors in MSCs was also confirmed at the protein level using subtypespecific antibodies for immunostaining. It turned out that each tested MSC colony (n = 7) contained a small (2-4%) subpopulation of cells exhibiting α1-and α2-like immunoreactivity (Fig. 6B, C) . Although the α1-adrenoreceptor is ubiquitously involved in Ca 2+ signaling [39] , coupling of the α2 isoform to PLC and Ca 2+ mobilization has also been documented [40] . Thus, the expression of α1B or α2A or both isoforms in a MSC responsive to noradrenaline (Fig. 2) would be quite relevant. In contrast, β2-adrenoreceptors are generally coupled by G-proteins to adenylate cyclase [41] , and those should not necessarily be present in a MSC generating Ca 2+ transients to noradrenaline. It was therefore unclear whether the detected adrenoreceptors (Fig. 6) were expressed in the same cell or there were separate MSC subpopulations distinguishable by specific expression profiles of these receptor proteins. To address this issue, we performed recordings using agonists and antagonists specific for the α1-, α2-, and β-subtypes in the adrenoreceptor family. Overall, 35 noradrenaline-responsive cells were treated with phenylephrine and/or cirazoline and prazosin (α1-agonists and antagonist, respectively) as well as with guanobenz and/or B-HT 933 and yohimbine (α2-agonists and antagonist, respectively). Most of them (29 cells, 83%) were irresponsive to phenylephrine (1-10 μM), and their noradrenaline responses were not inhibited by 10 μM prazosin. In contrast, guanobenz (50 μM) and B-HT 933 (10 μM) were quite effective (Fig. 7A, B) . Moreover, 1 μM yohimbine dumped cellular responses to noradrenaline and guanobenz (Fig. 7A, B) . Six cells (17%) were sensitive to both 10 μM phenylephrine and 10 μM guanobenz (Fig. 7C) . These findings indicate that the α2-subtype, evidently α2A is the dominant adrenoreceptor, although in a minor MSC subpopulation, both α1-and α2-isoforms could be involved in adrenergic transduction.
In a number of experiments, we aimed at β-adrenoreceptors by treating noradrenaline-responsive MSCs with the β-agonist isoproterenol and β-antagonist alprenolol. Isoproterenol (1-10 μM) as such negligibly affected intracellular Ca 2+ at rest and insignificantly modulated cell responsivity to noradrenaline (n = 9) (Fig. 7D) . Surprising in light of this finding was that all assayed cells became irresponsive in the presence of alprenolol (5-10 μM) that acted reversibly (n = 16) (Fig. 7D) . At the moment we have no validated explanation of this phenomenon. In any event, the described effects of the subtype specific agonists and antagonists (Fig. 7) can be considered as an indication that all adrenoreceptor isoforms detected by RT-PCR are functional in MSCs. Moreover, the data provide functional evidence that α2-and β2-subtypes are co-expressed.
Discussion
Here we studied Ca 2+ signaling in mesenchymal stromal cells (MSCs) derived from the human adipose tissue. As a whole, a population of cultured MSCs exhibited functional heterogeneity in terms of their responsivity to a variety of GPCR agonists, including ATP, GABA, noradrenaline and some others. Although all first messengers tested were effective, only a relatively small group of MSCs was specifically responsive to the particular agonist (Fig. 1) . Consistently with previous reports (reviewed in [9] ), some MSCs that were basically irresponsive to the agonists generated spontaneous Ca 2+ oscillations under our recording conditions (Fig. 1 ). The present work was specifically focused on adrenergic MSCs. The physiological analysis, RT-PCR, and immunostaining revealed the functional expression of α1B-, α2A-, and β2-adrenoreceptors (Figs. 6 and 7) . The experiments with the subtype specific agonists pointed at the α2A-isoform as a key adrenoreceptor endowing MSCs with sensitivity to noradrenaline, although α1B-isoform also might be involved (Fig. 7) . The β-agonist isoproterenol negligibly affected intracellular Ca 2+ in resting MSCs and their sensitivity to noradrenaline ( Fig. 7D) , indicating that β2-adrenoreceptors are not directly coupled to Ca 2+ mobilization in MSCs. In light of this finding, surprising was that cells became insensitive to noradrenaline in the presence of alprenolol (Fig. 7D) that normally antagonizes to G-protein signaling initiated by classical agonists of β-adrenoreceptors. Although underlying mechanism(s) remains to be elucidated, theoretically, the inhibitory effects of alprenolol could be rationally explained based on the concept of biased agonism [42] [43] [44] . Indeed, this compound has been documented to stimulate coupling of β1-and β2-adrenoreceptors to ERK1/2 kinase via β-arrestin [45, 46] . It is therefore possible that alprenolol affected noradrenaline responses (Fig. 7D ) by stimulating β2-adrenoreceptors as a biased agonist capable of initiating β-arrestin signaling, currently unidentified in MSCs. This arrestin-dependent pathway might interfere with the adrenergic transduction machinery, rendering MSCs irresponsive. The body of evidence implicates the classical phosphoinositide cascade in mediating adrenergic signaling in MSCs. In particular, noradrenaline responses were specifically suppressed by the PLC inhibitor U73122 and IP 3 receptor blocker 2-APB (Fig. 2) . Hence, PLC stimulation, IP 3 production, and IP 3 receptor activation appear to be obligatory events in noradrenaline transduction. Yet, the reduction of bath Ca 2+ from 2 mM to 260 nM subtly affected the kinetics and magnitude of MSC responses to saturating noradrenaline but rendered cells less sensitive to the agonist at intermediate concentrations (Fig. 2B, C) (Fig. 2C ).
The responsivity of adrenergic MSCs followed a peculiar dose dependence: noradrenaline never elicited small or intermediate responses but initiated Ca 2+ transients basically being large and quite similar at all concentrations above the threshold. A number of MSCs exhibited robust noradrenaline responses within 30-40 min, thus allowing for the reliable assay of their responsivity over a wide range of agonist concentrations (Fig. 3A, B) . These cells exhibited step-like dose dependences with the threshold noradrenalin concentration of 100-200 nM (Fig. 3C) . In many cases, responses of MSCs to adrenergic agonists varied with time and/or were liable to rundown. Presumably, such cells showed somewhat irregular dose-response curves like those depicted in Fig. 3D . Even so, all obtained dose dependencies evidence for the allor-nothing character of noradrenaline responsivity. Amazingly, the key features of noradrenaline responses, including the all-or-nothing behavior, were correctly simulated with Ca 2+ uncaging, provided that it produced sufficient Ca 2+ bursts in the MSC cytoplasm (Fig. 4) . In more detail, short UV pulses elicited relatively small Ca 2+ transients that relaxed monotonically. In contrast, more prolonged light stimuli, which liberated sufficient quantity of Ca 2+ ions, triggered biphasic Ca 2+ signals that were rather similar to noradrenaline responses by kinetics and magnitude (Fig. 4A, B) . Based on these findings, we inferred that adrenergic transduction occurs in two key steps. Initially, an adrenergic agonist produces a relatively small Ca 2+ signal, which is most likely to rise gradually with stimulus intensity, given that the experimentally recorded Ca 2+ transients were delayed relative to noradrenaline application in a dose-dependent way (Fig. 3E,  F ). When reaching the threshold level, this initial Ca 2+ signal triggers a regenerative process mediated by the CICR mechanism that eventually produces a global Ca 2+ response of the maximal value (Fig. 3A, B) .
Although qualitatively, the above point of view integrates well the diverse findings of the present work, two apparent inconsistencies should be noted. The first relates to the nature of all-or-nothing Ca 2+ signals elicited by adrenergic agonists. One could expect that an initial agonist-dependent Ca 2+ rise preceding CISR should have been present in recording traces (Fig. 3A, B (Fig. 4D) suggest that CICR in MSCs does not require IP 3 production. It thus appears that adrenergic transduction implicates IP 3 receptors in two fundamentally different signaling events, one requiring PLC stimulation and another being PLC-independent. Note however that intracellular signaling involves distinct subpopulations of IP 3 receptors that differ in their sensitivity to IP 3 and Ca 2+ and may operate in physically separated Ca 2+ compartments [31, 48] . The necessary functional specialization of IP 3 receptors can also be achieved with the assistance of the Са 2+ -binding protein CIB1 that stimulates all three IP 3 R isoforms in a Ca 2+ -dependent manner even in the absence of IP 3 [49] . Thus, under certain conditions, IP 3 receptor-mediated CICR may not require IP 3 production (Fig. 4D ).
Conclusions
Based on the main finding of the present study, we propose the following minimal model of adrenergic transduction in MSCs (Fig. 8) Fig. 4A ) usually exceeded the number of cells responsive to adrenergic agonists. This suggests that the CICR mechanism not only mediates adrenergic transduction but may also be involved in Ca 2+ signaling initiated in MSCs by other first messengers (Fig. 1A) . 
